SynaptixBio_BACKGROUND_dark2.png

Danish biotech profile is helping to establish its fourth company abroad

Updated: Dec 16, 2021

Bent Jakobsen, who has previously co-founded three biotech companies abroad, is now helping to establish his fourth of its kind, Synaptixbio, which will tackle one of the world's rarest neurological disorders.


To continue reading please go to the article on MedWatch

26 views0 comments

Recent Posts

See All

Dr Dan Williams, CEO and Co-Founder of new biotech business SynaptixBio, discusses how the search is on to find the first treatment for one of the world’s rarest diseases, TUBB4A-associated leukodystr

SynaptixBio, an Oxford, UK-based research company, has been launched by a worldwide team of medical and pharmaceutical scientists to develop the world’s first disease modifying treatment for leukodyst